Generic Zyrtec Recalled Over Heartburn Drug Contamination July 24

Unique Pharmaceutical Laboratories is recalling four lots of generic Zyrtec tablets sold nationwide after discovering contamination with ranitidine, a heartburn medication. A pharmacy technician spotted discolored and red-dotted pills while counting the allergy medication, triggering the recall. People with hypersensitivity to ranitidine could face life-threatening reactions including anaphylaxis. No illnesses have been reported so far.

What was contaminated and how it was found

The recall affects cetirizine hydrochloride 5 mg tablets distributed by Rising Pharma Holdings Inc. in 100-tablet bottles. The four affected lot numbers are GY825029, GY825030, GY825031, and GY825032, all set to expire in October 2028. A pharmacy technician discovered red dots and discolored pills while counting the medication before dispensing it to a customer. The wrong-colored tablets prompted the immediate alert to the FDA.

Why ranitidine contamination is dangerous

Ranitidine, formerly sold as Zantac, treats heartburn and indigestion. For people with hypersensitivity to ranitidine, ingesting contaminated tablets could cause severe reactions. Potential life-threatening effects include anaphylaxis, hypotension, shortness of breath, difficulty swallowing, and loss of consciousness. The FDA stated there is a reasonable probability of serious adverse events. To date, no illnesses linked to the contamination have been reported.

How to check your bottles and get help

Consumers should check the lot number printed on the bottle side. If your cetirizine 5 mg tablets match one of the four recalled lot numbers expiring October 2028, do not use them. Rising Pharma Holdings is arranging returns of all recalled drugs. Contact the company at 1-844-874-7464 (8 a.m. to 5 p.m. ET, Monday through Friday) or email [email protected] or [email protected] with questions.

Final Thoughts

This recall affects only four specific lot numbers of generic Zyrtec sold nationwide. Check your bottle for the lot number and expiration date. If you have one of the recalled batches and no hypersensitivity to ranitidine, risk is lower, but contact Rising Pharma to arrange a return.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.